The number of individual cases identified in EudraVigilance for COVID-19 VACCINE JANSSEN (AD26.COV2.S) is 71,635 (up to 31/12/2023)
Evaluating Condition
Number of individual cases by Age Group
Pivot Table Prompts
Sections
Age Group
Cases
%
Not Specified
4,876
6.8%
0-1 Month
19
0.0%
2 Months - 2 Years
53
0.1%
3-11 Years
6
0.0%
12-17 Years
117
0.2%
18-64 Years
61,489
85.8%
65-85 Years
4,648
6.5%
More than 85 Years
427
0.6%
Total
71,635
100.0%
saw.dll?DocPart&StateID=1591064180
Evaluating Condition
Number of individual cases by Sex
Pivot Table Prompts
Sections
Sex
Cases
%
Female
37,925
52.9%
Male
30,925
43.2%
Not Specified
2,785
3.9%
Total
71,635
100.0%
saw.dll?DocPart&StateID=1591064181
Evaluating Condition
Number of individual cases by Geographic Origin (EEA/Non-EEA)
Pivot Table Prompts
Sections
Occurrence Country EEA/Non EEA
Cases
%
European Economic Area
59,360
82.9%
Non European Economic Area
12,275
17.1%
Not Specified
0
Total
71,635
100.0%
saw.dll?DocPart&StateID=1591064182
Evaluating Condition
Number of individual cases by Reporter Group
Pivot Table Prompts
Sections
Reporter Group
Cases
%
Healthcare Professional
27,669
38.6%
Non Healthcare Professional
43,966
61.4%
Not Specified
0
Total
71,635
100.0%
saw.dll?DocPart&StateID=1591064183
Evaluating Condition
For the interpretation of the results, please refer to the key considerations at www.adrreports.eu
Evaluating Condition
Move a group to the "Groups with Permission" area to allow members to use this Saved Customization. Check the box next to a group to make this Saved Customization its default.
